Previous close | 1,798.50 |
Open | 0.00 |
Bid | 1,765.00 x 49400 |
Ask | 1,799.99 x 13500 |
Day's range | 0.00 - 0.00 |
52-week range | |
Volume | |
Avg. volume | 3,443 |
Market cap | 4.56T |
Beta (5Y monthly) | 0.36 |
PE ratio (TTM) | 30.96 |
EPS (TTM) | 58.07 |
Earnings date | 27 Apr 2022 - 02 May 2022 |
Forward dividend & yield | 56.53 (3.12%) |
Ex-dividend date | 14 Sept 2022 |
1y target est | N/A |
RAHWAY, N.J., August 16, 2022--FDA Accepts Submission of sNDA for LYNPARZA® in Combination With Abiraterone and Prednisone for Patients With mCRPC and Grants Priority Review
RAHWAY, N.J. & CAMBRIDGE, Mass., August 16, 2022--Merck and Orna Therapeutics Collaborate to Advance Orna’s Next Generation of RNA Technology
Robust sales contribution across operating segments drove Illumina's (ILMN) Q2 top line.